Acro Biomedical Co Stock Performance
| ACBM Stock | USD 0.02 0.00 0.00% |
ACRO Biomedical holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -51.33, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning ACRO Biomedical are expected to decrease by larger amounts. On the other hand, during market turmoil, ACRO Biomedical is expected to outperform it. Use ACRO Biomedical information ratio, skewness, as well as the relationship between the Skewness and day median price , to analyze future returns on ACRO Biomedical.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ACRO Biomedical Co are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile fundamental drivers, ACRO Biomedical displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
ACRO |
ACRO Biomedical Relative Risk vs. Return Landscape
If you would invest 0.07 in ACRO Biomedical Co on November 1, 2025 and sell it today you would earn a total of 2.15 from holding ACRO Biomedical Co or generate 3071.43% return on investment over 90 days. ACRO Biomedical Co is currently generating 15.625% in daily expected returns and assumes 125.0% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than ACRO, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ACRO Biomedical Target Price Odds to finish over Current Price
The tendency of ACRO Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.02 | 90 days | 0.02 | about 8.0 |
Based on a normal probability distribution, the odds of ACRO Biomedical to move above the current price in 90 days from now is about 8.0 (This ACRO Biomedical Co probability density function shows the probability of ACRO Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days ACRO Biomedical Co has a beta of -51.33. This suggests as returns on its benchmark rise, returns on holding ACRO Biomedical Co are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, ACRO Biomedical is expected to outperform its benchmark. In addition to that ACRO Biomedical Co has an alpha of 49.1602, implying that it can generate a 49.16 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). ACRO Biomedical Price Density |
| Price |
Predictive Modules for ACRO Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ACRO Biomedical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ACRO Biomedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ACRO Biomedical is not an exception. The market had few large corrections towards the ACRO Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ACRO Biomedical Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ACRO Biomedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 49.16 | |
β | Beta against Dow Jones | -51.33 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.12 |
ACRO Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ACRO Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ACRO Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ACRO Biomedical is way too risky over 90 days horizon | |
| ACRO Biomedical has some characteristics of a very speculative penny stock | |
| ACRO Biomedical appears to be risky and price may revert if volatility continues | |
| ACRO Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| About 50.0% of the company shares are held by company insiders |
ACRO Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ACRO Pink Sheet often depends not only on the future outlook of the current and potential ACRO Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ACRO Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 47.8 M | |
| Cash And Short Term Investments | 95.2 K |
ACRO Biomedical Fundamentals Growth
ACRO Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of ACRO Biomedical, and ACRO Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ACRO Pink Sheet performance.
| Return On Equity | -29.78 | |||
| Return On Asset | -15.5 | |||
| Operating Margin | (17.61) % | |||
| Current Valuation | 240.18 M | |||
| Shares Outstanding | 60.04 M | |||
| Price To Book | 487.98 X | |||
| Price To Sales | 267.90 X | |||
| Revenue | 1.2 M | |||
| EBITDA | (7.69 M) | |||
| Cash And Equivalents | 12.11 K | |||
| Total Debt | 59.44 K | |||
| Debt To Equity | 0.10 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | 299.33 K | |||
| Earnings Per Share | (0.20) X | |||
| Total Asset | 761.08 K | |||
About ACRO Biomedical Performance
By examining ACRO Biomedical's fundamental ratios, stakeholders can obtain critical insights into ACRO Biomedical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that ACRO Biomedical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana. Acro Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about ACRO Biomedical performance evaluation
Checking the ongoing alerts about ACRO Biomedical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for ACRO Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ACRO Biomedical is way too risky over 90 days horizon | |
| ACRO Biomedical has some characteristics of a very speculative penny stock | |
| ACRO Biomedical appears to be risky and price may revert if volatility continues | |
| ACRO Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| About 50.0% of the company shares are held by company insiders |
- Analyzing ACRO Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ACRO Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining ACRO Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ACRO Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ACRO Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ACRO Biomedical's pink sheet. These opinions can provide insight into ACRO Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in ACRO Pink Sheet
ACRO Biomedical financial ratios help investors to determine whether ACRO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ACRO with respect to the benefits of owning ACRO Biomedical security.